GLP-1 drugs raise pancreatitis risk in type 2 diabetes

02/26/2013 | U.S. News & World Report

Type 2 diabetes patients who took glucagon-like peptide-1-based drugs such as sitagliptin and exenatide had a twofold increased risk of hospitalization for acute pancreatitis within 60 days of starting treatment compared with those who took other diabetes medications, according to a study in JAMA Internal Medicine.

View Full Article in:

U.S. News & World Report

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID